Italy’s pharmaceutical industry is undergoing a remarkable transformation, fueled by scientific innovation, digital health advancements, biotechnology breakthroughs, and a growing commitment to diversity in leadership. While Italy has long been recognized as one of Europe’s pharmaceutical powerhouses, women leaders are increasingly shaping the sector’s future through strategic vision, operational excellence, investment leadership, and groundbreaking contributions to healthcare innovation.
From multinational pharmaceutical executives and life sciences investors to technology leaders and legal experts, these women are helping redefine how medicines are developed, manufactured, regulated, and delivered. Their influence extends beyond corporate boardrooms, impacting healthcare systems, research ecosystems, and the next generation of women entering STEM and pharmaceutical careers.
Italy stands among Europe’s leading pharmaceutical markets, with the industry contributing significantly to research, exports, biotechnology innovation, and employment. As the sector embraces artificial intelligence, personalized medicine, digital therapeutics, and sustainable manufacturing, women leaders are taking center stage in driving meaningful change.
The women featured on this list are not only leading organizations but also creating opportunities for innovation, championing diversity, supporting life sciences entrepreneurship, and influencing healthcare outcomes at national and international levels. Their leadership reflects the evolving face of Italy’s pharmaceutical landscape and demonstrates the growing importance of inclusive leadership in one of the world’s most critical industries.
Italy’s Top 10 Influential Women in the Pharmaceutical Industry to Watch in 2026
1. Arianna Gregis
Leading Bayer Italia into a New Era of Pharmaceutical Innovation
Arianna Gregis has rapidly emerged as one of the most influential women in Italy’s pharmaceutical sector following her appointment as Chief Executive Officer of Bayer Italia and President of Bayer Healthcare Manufacturing in 2026. With more than two decades of experience in the pharmaceutical industry and a career spanning both international finance and life sciences, Gregis represents the next generation of strategic healthcare leadership in Europe. She joined Bayer in 2006 and has held several senior leadership positions across Italy and international markets before assuming the company’s top role in the country.
Under her leadership, Bayer Italia is strengthening its focus on therapeutic innovation, scientific research, manufacturing excellence, and strategic partnerships within the healthcare ecosystem. Gregis continues to lead Bayer’s Pharmaceuticals Division while overseeing the company’s broader operations, placing her at the center of some of Italy’s most important healthcare and life sciences initiatives. Her commitment to innovation, industrial growth, and sustainable healthcare solutions makes her a standout figure among the women shaping the future of Italy’s pharmaceutical industry in 2026.
2. Silvia Nencioni
Driving Inclusive Leadership at Boiron Italia
As President and CEO of Boiron Italia, Silvia Nencioni oversees one of the country’s most recognized healthcare organizations. Her leadership has become a notable example of how diversity and inclusion can strengthen corporate performance and innovation.
Nencioni has cultivated a workplace culture where female representation is not simply encouraged but actively reflected throughout leadership positions. Under her guidance, Boiron Italia has maintained a strong commitment to patient-centered healthcare while fostering an executive team that mirrors modern workforce realities.
Her leadership style combines strategic business management with a strong focus on people development, making her one of the most admired pharmaceutical executives in Italy today.
3. Donatella Doppio
Transforming Pharma Through Technology and Data Innovation
The future of healthcare increasingly depends on technology, and Donatella Doppio sits at the intersection of both worlds. As Regional Vice President for Oracle Italy, she plays a critical role in helping pharmaceutical organizations modernize operations through advanced technologies, cloud infrastructure, data analytics, and digital transformation initiatives.
Doppio works closely with leading pharmaceutical companies, helping them improve research capabilities, optimize supply chains, strengthen regulatory compliance, and enhance patient outcomes through data-driven decision-making.
Her expertise demonstrates how technology is becoming a strategic pillar of pharmaceutical success, positioning her among the most influential women shaping Italy’s life sciences ecosystem.
4. Francesca Chiara Gennaro
Powering the Next Generation of Life Sciences Innovation
Innovation requires capital, and Francesca Chiara Gennaro is one of the key figures helping bring healthcare breakthroughs to market. As Chief Investment Officer at CDP Venture Capital SGR, she oversees investments that support promising startups and emerging technologies within Italy’s healthcare and life sciences sectors.
Her work focuses on identifying high-potential companies capable of transforming patient care through innovative therapies, medical technologies, biotechnology solutions, and digital health platforms.
By facilitating access to funding and growth opportunities, Gennaro plays an essential role in strengthening Italy’s healthcare innovation ecosystem and accelerating scientific progress across the country.
5. Annalisa Adani
Redefining Leadership and Diversity in Rare Disease Healthcare
Annalisa Adani serves as Vice President and General Manager for Sobi across Italy, Greece, Malta, and Cyprus, where she oversees operations focused on improving the lives of patients with rare diseases and specialized healthcare needs.
Beyond commercial success, Adani has earned recognition for fostering highly diverse leadership structures and promoting inclusive governance models. Her commitment to creating opportunities for women and underrepresented professionals has become a defining aspect of her leadership approach.
As healthcare organizations increasingly prioritize diversity as a business advantage, Adani continues to demonstrate how inclusive leadership can drive both organizational performance and social impact.
6. Elena Zambon
Leading a Pharmaceutical Legacy into the Future
As President of Zambon Group, Elena Zambon represents the third generation of leadership within one of Italy’s most respected pharmaceutical enterprises. Under her stewardship, the company continues to expand its global footprint while investing heavily in research, innovation, and sustainable healthcare solutions.
Zambon is widely recognized for her advocacy of women in science, technology, engineering, and mathematics (STEM). She actively promotes entrepreneurship, innovation, and leadership opportunities for women across Europe’s healthcare sector.
Her ability to balance tradition with innovation has positioned her as one of Italy’s most influential pharmaceutical leaders and an inspiring role model for future generations.
7. Lucia Aleotti
Steering International Growth at Menarini Group
Few names are as synonymous with Italian pharmaceuticals as Lucia Aleotti. As a prominent shareholder and board member of Menarini Group, she has played a significant role in guiding the company’s international expansion and strengthening its position among the world’s leading pharmaceutical organizations.
Aleotti has consistently advocated for research-driven growth and global competitiveness. Her strategic vision has helped elevate Italian pharmaceutical innovation onto the international stage while preserving the entrepreneurial spirit that has defined Menarini’s success.
Her long-standing influence in the industry makes her one of the most respected business leaders in European healthcare.
8. Cristina Scocchia
Bringing Consumer Health and Wellness Leadership to New Heights
Cristina Scocchia has built a reputation as one of Italy’s most accomplished executives. Currently serving as CEO of illycaffè, she previously led KIKO Milano and held senior leadership positions at L’Oréal Italy and Procter & Gamble.
Although her primary expertise spans consumer goods, beauty, and wellness, her impact on health-conscious consumer markets and innovation-driven business strategies has been substantial. She has consistently demonstrated how strong branding, customer engagement, and operational excellence can drive sustainable growth.
Scocchia’s leadership journey serves as a powerful example of cross-sector influence, where expertise from consumer wellness industries increasingly overlaps with healthcare and pharmaceutical innovation.
9. Monica Poggio
Leading Bayer Italia Through a New Era of Healthcare Innovation
As President and CEO of Bayer Italia, Monica Poggio oversees the operations of one of the world’s most recognized healthcare and life sciences companies within the Italian market.
Her leadership encompasses pharmaceutical innovation, healthcare accessibility, digital transformation, sustainability initiatives, and patient-focused solutions. Poggio has been instrumental in strengthening Bayer’s role in advancing modern healthcare while navigating a rapidly evolving regulatory and technological landscape.
Her ability to align business growth with healthcare impact has made her one of Italy’s most influential pharmaceutical executives.
10. Barbara La Tella
Protecting Innovation Through Pharmaceutical Intellectual Property Leadership
Innovation in pharmaceuticals depends heavily on intellectual property protection, and Barbara La Tella has emerged as one of Italy’s foremost experts in pharmaceutical and biotechnology law.
Specializing in intellectual property strategy, patent protection, copyrights, and brand defense, she advises leading life sciences organizations on safeguarding their innovations in increasingly competitive global markets.
As biotechnology, personalized medicine, and AI-driven drug discovery continue to evolve, legal expertise becomes more critical than ever. La Tella’s work ensures that scientific breakthroughs receive the protection needed to reach patients while maintaining commercial viability.
The Growing Influence of Women in Italy’s Pharmaceutical Industry
The pharmaceutical industry is entering a new era defined by scientific discovery, digital transformation, biotechnology advancement, and patient-centered innovation. Women leaders are playing a critical role in shaping this evolution, bringing diverse perspectives and forward-thinking strategies to some of the industry’s most important challenges.
The achievements of Graziella Molinari, Silvia Nencioni, Donatella Doppio, Francesca Chiara Gennaro, Annalisa Adani, Elena Zambon, Lucia Aleotti, Cristina Scocchia, Monica Poggio, and Barbara La Tella highlight the breadth of talent driving Italy’s pharmaceutical sector forward.
Their contributions extend far beyond their individual organizations. They are influencing policy, fostering innovation, mentoring future leaders, advancing healthcare access, and helping position Italy as a global center for pharmaceutical excellence. As 2026 unfolds, these remarkable women will undoubtedly remain among the most influential figures shaping the future of healthcare and life sciences both in Italy and beyond.
Read more Top List at Apple Unveils AI-Powered Siri at WWDC 2026 as Tim Cook Delivers Emotional Farewell
